Who regulates your products? – Elexes
Elexes Medical Consulting

The first step towards bringing your product to the market is understanding which center at the FDA shall regulate your product. The primary centers: 

  • CDRH – Center for Devices and Radiological Health
  • CDER –  Center for Drug Evaluation and Research
  • CBER – Center for Biologics Evaluation and Research

While for most products a categorization between drugs, biologics, and medical devices is easy, in some cases this can be a challenge, especially if a product is a consumer product or mobile app with medical application or a combination product, injection, drug delivery system, etc. However, if one asks the following simple questions, this distinction can be easy: 

  1. How would you define your product – meets the definition of a drug, a biologic or a device?
  2. What is the primary mode of action of your product? 
  3. What category you think it should be under – sometimes the category that you might think first would not be the right one, so review w.r.t. indications for use and competitors.  

The right center will allow you to hire the right regulatory expert to help navigate through the regulatory process and efficiently get to the market and maintain compliance henceforth.

Leave a Reply

You may also like

Medical Devices

Breakthrough vs. STeP, which one is more apt for your medical device?

Both STeP and Breakthrough Device Program comprises 2 Phases.  In the first Phase, sponsors formally request inclus

Medical Devices

Clinical trials in South Africa – worldwide accepted data

Clinical trials being a resource, cost, and time extensive process, identifying the right location for a clinical trial

Medical Devices

RUO – A Market Opportunity for IVD companies

Getting an IVD product to the market is a cumbersome task and takes several months to over a year to finally get everyth

Medical Devices

Official Number is now 15 – MDD to MDR + IVDD to IVDR Planning

Everyone knows that the advent of MDR was postponed, and the new regulation shall be in full force from May 26, 2021. As